Latest News

Alzheimer's prevention trial to monitor reactions to higher disease risk status

A new clinical trial will soon begin testing whether early medical intervention in people at risk for Alzheimer's can slow down progression of disease pathology before symptoms emerge. As part of the overall prevention trial, neurodegenerative ethics experts will monitor how learning about their risk of developing Alzheimer's impacts trial participants.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • New technologies to help patients with Parkinson's disease

  • Tweeting about sexism could improve a woman's wellbeing

  • Treating Cerebral Malaria: New Molecular Target Identified

  • Transgender kids show consistent gender identity across measures

  • Blame men for political gridlock, study says

  • Complex environments push 'brain' evolution

  • Heavy drinking in middle-age may increase stroke risk more than traditional factors

  • FDA approves first-of-kind device to treat obesity

  • Many religious people view science favorably, but reject certain scientific theories

  • Privacy challenges: Just four vague pieces of info can identify you, and your credit card

  •